Skip to content

Accurate localization and characterization of sentinel lymph nodes using contrast-enhanced ultrasound

Accurate localization and characterization of sentinel lymph nodes using contrast-enhanced ultrasound

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080083
Enrollment
Unknown
Registered
2024-01-19
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer, melanoma

Interventions

Breast cancer group/ Melanoma group:None

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with breast cancer or malignant melanoma confirmed by pathology; 2. Age =18; 3. Obtain an informed consent form signed by the patient or their representative.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of lymph node drainage surgery; 2. Patients with a history of chemotherapy; 3. Patients who are allergic to eggs or egg products; 4. Hypersensitivity reactions to other components of Sonazoles; 5. Recent acute coronary syndrome or clinically unstable ischemic heart disease; 6. Adult respiratory distress syndrome; 7. Severe emphysema; 8. History of pulmonary vasculitis or pulmonary embolism; 9. Known right to left diversion; 10. Severe pulmonary hypertension or uncontrolled systemic hypertension.

Design outcomes

Primary

MeasureTime frame
CEUS parameters;

Countries

China

Contacts

Public ContactCHEN LUZENG

Peking University First Hospital

chenluzeng@bjmu.edu.cn+86 188 1032 2856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026